Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent histone deacetylase inhibitors in cancer therapy
Roza Parveen, Divya Harihar, Biswa Prasun Chatterji
Cancer (2023) Vol. 129, Iss. 21, pp. 3372-3380
Closed Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

HDAC-targeting epigenetic modulators for cancer immunotherapy
Binbin Cheng, Wei Pan, Yao Xiao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 265, pp. 116129-116129
Closed Access | Times Cited: 29
Converting “cold” to “hot”: epigenetics strategies to improve immune therapy effect by regulating tumor‐associated immune suppressive cells
Yijia Tang, Guangzu Cui, Haicong Liu, et al.
Cancer Communications (2024) Vol. 44, Iss. 6, pp. 601-636
Open Access | Times Cited: 10
Stack-HDAC3i: A high-precision identification of HDAC3 inhibitors by exploiting a stacked ensemble-learning framework
Watshara Shoombuatong, Ittipat Meewan, Lawankorn Mookdarsanit, et al.
Methods (2024) Vol. 230, pp. 147-157
Closed Access | Times Cited: 6
The Role of Rosavin in the Pathophysiology of Bone Metabolism
Piotr Wojdasiewicz, Paweł Turczyn, Anna Lach-Gruba, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2117-2117
Open Access | Times Cited: 5
DNA and RNA Methylation in Rheumatoid Arthritis—A Narrative Review
Kajetan Kiełbowski, Estera Bakinowska, Anna Gorący, et al.
Epigenomes (2025) Vol. 9, Iss. 1, pp. 2-2
Open Access
Anticancer properties of histone deacetylase inhibitors – what is their potential?
Kajetan Kiełbowski, Agata Szwedkowicz, Paulina Plewa, et al.
Expert Review of Anticancer Therapy (2025), pp. 1-16
Closed Access
Pan-cancer analysis of the transcriptional expression of histone acetylation enzymes in solid tumors defines a new classification scheme for gliomas
Junhao Zhang, Lingbo Li, Aiwei Tang, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Discovery of a potential hematologic malignancies therapy: Selective and potent HDAC7 PROTAC degrader targeting non-enzymatic function
Yuheng Jin, Xuxin Qi, Xiaoli Yu, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Androgen receptor dynamics in prostate cancer: from disease progression to treatment resistance
Caihong Li, Dongkai Cheng, Peng Li
Frontiers in Oncology (2025) Vol. 15
Open Access
NAD+ Metabolism Reprogramming Drives SIRT1‐Dependent Deacetylation Inducing PD‐L1 Nuclear Localization in Cervical Cancer
Xinyi Lu, Pingping Jin, Qianyun Tang, et al.
Advanced Science (2025)
Open Access
Design, synthesis and biological evaluation of novel hydroxamic acid-derived histone deacetylase inhibitors bearing a 2-oxoindoline scaffold as potential antitumor agents
Trần Thị Lan Hương, Hwa Kyung Kim, Nguyen Duc Thien, et al.
Bioorganic & Medicinal Chemistry (2025) Vol. 122, pp. 118143-118143
Closed Access
Histone modification inhibitors: An emerging frontier in thyroid Cancer therapy
Qi Wang, Shu Sun, Guojun Sun, et al.
Cellular Signalling (2025), pp. 111703-111703
Closed Access
Acetylation: a new target for protein degradation in cancer
Callie E.W. Crawford, George M. Burslem
Trends in cancer (2025)
Closed Access
HAT1/HDAC2 mediated ACSL4 acetylation confers radiosensitivity by inducing ferroptosis in nasopharyngeal carcinoma
Peijun Zhou, Xingzhi Peng, Kun Zhang, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Discovery of a Highly Potent and Selective HDAC8 Degrader: Advancing the Functional Understanding and Therapeutic Potential of HDAC8
Yufeng Xiao, Nikee Awasthee, Yi Liu, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 15, pp. 12784-12806
Closed Access | Times Cited: 4
The Role of Rosavin in the Pathophysiology of Bone Metabolism
Piotr Wojdasiewicz, Paweł Turczyn, Anna Lach-Gruba, et al.
(2024)
Open Access | Times Cited: 3
Identification of the tumor metastasis-related tumor subgroups overexpressed NENF in triple-negative breast cancer by single-cell transcriptomics
Guixin Wang, Cangchang Shi, Long He, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Histone deacetylase inhibitors for leukemia treatment: current status and future directions
Mohammad‐Salar Hosseini, Zohreh Sanaat, Mohammad Amin Akbarzadeh, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 3
Drug prioritization identifies panobinostat as a tailored treatment element for patients with metastatic hepatoblastoma
Salih Demir, Alina Hotes, Tanja Schmid, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 3
Research progress of LSD1-based dual-target agents for cancer therapy
Xiaojuan Yang
Bioorganic & Medicinal Chemistry (2024) Vol. 101, pp. 117651-117651
Closed Access | Times Cited: 2
Combined HDAC and eIF4A inhibition: A novel epigenetic therapy for pancreatic adenocarcinoma
Maryam Safari, Luigi Scotto, Agnès Basseville, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Discovery of a novel hybrid coumarin-hydroxamate conjugate targeting the HDAC1-Sp1-FOSL2 signaling axis for breast cancer therapy
Sujie Zhu, Wenjing Zhu, Kaihua Zhao, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Polyphyllin I Sensitizes Cisplatin-Resistant Human Cervical Cancer Cells to Cisplatin Treatment
Lu Zhang, Wenzhi Liu, Yu Li, et al.
Nutrition and Cancer (2024) Vol. 76, Iss. 7, pp. 656-665
Closed Access | Times Cited: 1
Evaluating the Role of Neddylation Modifications in Kidney Renal Clear Cell Carcinoma: An Integrated Approach Using Bioinformatics, MLN4924 Dosing Experiments, and RNA Sequencing
Dequan Liu, Guangzhen Wu, Shijin Wang, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 635-635
Open Access | Times Cited: 1
Research Progress on the Mechanism of Histone Deacetylases in Ferroptosis of Glioma
Meng Ma, Xifeng Fei, Dongyi Jiang, et al.
Oncology Reviews (2024) Vol. 18
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top